These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23570159)

  • 1. Leveraging high content screening for in vitro cytotoxicity assessment.
    Haskins JR
    Drug Discov Today; 2005; Suppl():1. PubMed ID: 23570159
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of novel high-throughput embryonic stem cell tests with new molecular markers for screening embryotoxic chemicals in vitro.
    Suzuki N; Ando S; Yamashita N; Horie N; Saito K
    Toxicol Sci; 2011 Dec; 124(2):460-71. PubMed ID: 21964422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Cell Toxicity Assays.
    Murray D; McWilliams L; Wigglesworth M
    Methods Mol Biol; 2016; 1439():245-62. PubMed ID: 27317000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of PC12 and cerebellar granule cell cultures for evaluating neurite outgrowth using high content analysis.
    Radio NM; Freudenrich TM; Robinette BL; Crofton KM; Mundy WR
    Neurotoxicol Teratol; 2010; 32(1):25-35. PubMed ID: 19559085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron oxide nanoparticle toxicity testing using high-throughput analysis and high-content imaging.
    Harris G; Palosaari T; Magdolenova Z; Mennecozzi M; Gineste JM; Saavedra L; Milcamps A; Huk A; Collins AR; Dusinska M; Whelan M
    Nanotoxicology; 2015 May; 9 Suppl 1():87-94. PubMed ID: 23859183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment.
    Wetmore BA; Wambaugh JF; Ferguson SS; Sochaski MA; Rotroff DM; Freeman K; Clewell HJ; Dix DJ; Andersen ME; Houck KA; Allen B; Judson RS; Singh R; Kavlock RJ; Richard AM; Thomas RS
    Toxicol Sci; 2012 Jan; 125(1):157-74. PubMed ID: 21948869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro high-throughput assay for screening reproductive and toxic effects of anticancer compounds.
    Edwards V; Benkendorff K; Young F
    Biotechnol Appl Biochem; 2014; 61(5):582-92. PubMed ID: 24650341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplexed high content screening assays create a systems cell biology approach to drug discovery.
    Taylor DL; Giuliano KA
    Drug Discov Today; 2005; Suppl():13-8. PubMed ID: 23570162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput assay development for combined in vitro toxicity screening of hit compounds and their metabolites in early drug-discovery stage.
    Siricilla S
    Bioanalysis; 2017 Jul; 9(13):959-961. PubMed ID: 28708435
    [No Abstract]   [Full Text] [Related]  

  • 10. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of toxicity and identification of distinct apoptosis profiles using a 384-well high-throughput flow cytometry screening platform.
    Luu YK; Rana P; Duensing TD; Black C; Will Y
    J Biomol Screen; 2012 Jul; 17(6):806-12. PubMed ID: 22496094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mitochondrial dysfunction and drug safety.
    Nadanaciva S; Will Y
    IDrugs; 2009 Nov; 12(11):706-10. PubMed ID: 19844857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
    Hampton SL; Kinnaird AI
    Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium to high throughput screening: microfabrication and chip-based technology.
    Wen Y; Zhang X; Yang ST
    Adv Exp Med Biol; 2012; 745():181-209. PubMed ID: 22437819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular chemosensitivity assays: an overview.
    Sumantran VN
    Methods Mol Biol; 2011; 731():219-36. PubMed ID: 21516411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of food-relevant chemicals in the ToxCast high-throughput screening program.
    Karmaus AL; Filer DL; Martin MT; Houck KA
    Food Chem Toxicol; 2016 Jun; 92():188-96. PubMed ID: 27103583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered.
    Bal-Price AK; Hogberg HT; Buzanska L; Coecke S
    Neurotoxicol Teratol; 2010; 32(1):36-41. PubMed ID: 19150401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise review: a high-content screening approach to stem cell research and drug discovery.
    Xia X; Wong ST
    Stem Cells; 2012 Sep; 30(9):1800-7. PubMed ID: 22821636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
    Evensen L; Micklem DR; Link W; Lorens JB
    Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Caenorhabditis elegans in high throughput neurotoxicological research.
    Helmcke KJ; Avila DS; Aschner M
    Neurotoxicol Teratol; 2010; 32(1):62-7. PubMed ID: 19087888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.